VIDA

ICYMI, we spoke with Wisia Wedzicha, MD, PhD last week about the BEACON Study, which aims to identify very early COPD in young smokers. In this highlight clip, she speaks about one of the strongest signals: vDPM Air Trapping. Full recording available at https://hubs.la/Q02_RMF20

Last chance to register for our Webinar with Wisia Wedzicha! Link below 👇

You're invited! Next week we'll be speaking with Wisia Wedzicha, MD, PhD, about the BEACON Study, which aims to identify early signs of COPD 🫁 in young smokers. Bring your questions for live Q&A! Register here 👇 https://hubs.la/Q02-16Xh0

Did you know the average age of a COPD diagnosis is 73 (source: Morena et al., J Clin Med. 2023)? Since early diagnosis is so important in COPD, imagine if we could identify signs of disease significantly earlier (age 30-45)?! The BEACON study sought to answer this provocative question. Come hear about the results from Dr. Wedzicha in our upcoming webinar: https://lnkd.in/gNu9b8Rm About Wisia Wedzicha Dr. Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute, Imperial College, UK. She was awarded the BTS (British Thoracic Society) Medal in 2023 for contributions to respiratory medicine & science and the Helmholtz International Fellow award in 2014. Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She has published extensively on these topic and leads the British Early COPD Network cohort (BEACON) study. Prof. Wedzicha was Editor in Chief of the American Journal of Respiratory and Critical Care (“the Blue Journal”) from 2015 to 2021 and Editor in Chief of Thorax from 2002 to 2010. #COPDMonth #COPD #BEACON

We are honored to welcome Wisia Wedzicha, MD, PhD, an expert in COPD, as our next webinar guest! Dr. Wedzicha will dive into BEACON, a unique study uncovering the earliest signs of COPD in young smokers with normal spirometry 🫁. The BEACON study was featured on the cover of the Blue Journal (AJRCCM) 📖 earlier this year. 👉 Save your spot now: https://lnkd.in/gNu9b8Rm #COPD #BEACON #VIDAPresents #Webinar

New findings from Brightling et al. on the relationship between mucus plugging and air trapping: "A reduction in mucus plugging with tezepelumab treatment was correlated with a spatially-associated improvement in air trapping index." https://hubs.la/Q02YxKQ50 Authors: chris brightling, Å Hellqvist, S Diver, C Porsbjerg, E Israel, John D Newell, Sam Peterson, JM Sepena, AW Lindsley, A Megally, Lars Haug Nordenmark British Thoracic Society (BTS)

For our US employees, today is the day #VIDAVotes! 🇺🇸 All employees are granted a 4-hour window today, ensuring ample time to exercise our right to vote. See you at the polls! #gotv #vote #voting #electionday #teamVIDA

An excellent editorial by Cara Flynn and Chris Brightling: "Picture this: the future of imaging biomarkers in COPD." https://hubs.la/Q02W3MPq0 "In the near future, artificial intelligence, which is advancing rapidly in other areas of imaging, could be more widely adopted forCOPD imaging."

November is #Alpha1Awareness Month! Join us in raising awareness for Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can lead to serious lung and liver diseases. We are committed to help accelerate new therapies to these patients. ICYMI, here's our webinar with Dr. Barjaktarevic on the topic. https://hubs.la/Q02Wy3vZ0 #AATD

Happy Halloween 🎃 from VIDA! May your evening be full of treats. 👻 🕸️🕷️ #HappyHalloween #TeamVIDA